Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
Open Access
- 2 September 2024
- journal article
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (3) , 149-152
Abstract
Evaluation of bone marrow cytogenetic abnormalities in myelodysplastic syndrome is of great importance for confirming the clonal disease nature, determining the prognosis and choosing treatment tactics. Cytogenetic abnormalities are detected in 40–70 % of patients with myelodysplastic syndrome, and the variety of these abnormalities reflects the disease characteristics.This article describes the clinical follow-up of a patient with a myelodysplastic neoplasia with blast excess 1 and trisomy of chromosome 14.Keywords
This publication has 13 references indexed in Scilit:
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- Trisomy 14 in myeloid malignanciesCancer Genetics and Cytogenetics, 2001
- Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patientsLeukemia, 2000
- Trisomy 14 and LeukemiaCancer Genetics and Cytogenetics, 1998
- Isochromosome 14q in refractory anemiaCancer Genetics and Cytogenetics, 1997
- Trisomy 14 in hematologic diseases: Another non-random abnormality within myeloid proliferative disordersCancer Genetics and Cytogenetics, 1993
- Isochromosome 14q and leukemia with dysplastic featuresCancer Genetics and Cytogenetics, 1992
- Trisomy 14q in myelodysplastic syndromesCancer Genetics and Cytogenetics, 1990
- Trisomy 14 in refractory anemia with excess of blasts in transformationCancer Genetics and Cytogenetics, 1987
- Numerical chromosome aberrations in human neoplasiaCancer Genetics and Cytogenetics, 1986